7 studies found for:    Open Studies | "Influenza in Birds"
Show Display Options
RSS Create an RSS feed from your search for:
Open Studies | "Influenza in Birds"
Need help? See RSS Feeds
Choose a feed type:
Show studies that were first received in the last 14 daysShow studies that were first received in the last 14 days
Show studies added or modified in the last 14 daysShow studies that were added or modified in the last 14 days
Rank Status Study
1 Recruiting Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1
Condition: Influenza A Subtype H5N1 Infection
Interventions: Biological: IVACFLU-A/H5N1, 7.5 mcg;   Biological: Experimental: IVACFLU-A/H5N1, 15 mcg
2 Recruiting Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Immunosuppressive Conditions *aH5N1:Monovalent H5N1 Influenza Vaccine
Conditions: Influenza, Human;   Flu, Human;   Flu, Avian;   Influenza;   Influenza A Virus, H5N1 Subtype
Interventions: Biological: Novartis Investigational H5N1 vaccine;   Biological: Novartis Seasonal Influenza Vaccine
3 Recruiting Immunogenicity of ND1.1 by Delivery Directly to the Ileum
Condition: Avian Influenza
Intervention: Biological: ND1.1
4 Recruiting Experimental AD4-H5-VTN Vaccine in Healthy Volunteers
Condition: H5N1 Influenza
Interventions: Biological: Ad4-H5-VTN vaccination-tonsillar route;   Biological: Ad4-H5-vaccination-oral route
5 Unknown  Immunogenicity and Safety of Pandemic Influenza Vaccine in Healthy Adults
Condition: Pandemic Influenza
Intervention: Biological: Pandemic Influenza Vaccine (H5N1)
6 Recruiting Using Human Menstrual Blood Cells to Treat Acute Lung Injury Caused by H7N9 Bird Flu Virus Infection
Conditions: Acute Lung Injury;   Acute Respiratory Distress Syndrome (ARDS);   Multiple Organ Failure
Intervention: Drug: Menstrual blood stem cells
7 Recruiting Safety and Immunogenicity of Two Doses of aH5N1 Vaccine in Adult and Elderly Subjects With and Without Underlying Medical Conditions
Conditions: Influenza,;   Flu,
Interventions: Biological: Novartis Investigational H5N1 vaccine;   Biological: Novartis Seasonal Influenza Vaccine

Indicates status has not been verified in more than two years